drugset / Trial / NCT01596426
Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years
Non-randomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine the dosing strategy for adolescents aged 2 to 5 years.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Granisetron | Other / unclassified | — | Other |